Turnstone Biologics Corp. TSBX
We take great care to ensure that the data presented and summarized in this overview for Turnstone Biologics Corp. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TSBX
Top Purchases
Top Sells
About TSBX
Insider Transactions at TSBX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2023
|
Davis Jerel |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Davis Jerel |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
1,133,987
+41.98%
|
-
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders